Andere talen Hisamitsu Pharmaceutical Co., Inc.

Aandelen

4530

JP3784600003

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.819 ^JPY	-0,10%		+1,03%	-11,41%

11/04	Winst toerekenbaar aan Hisamitsu Pharmaceutical 19% hoger in boekjaar 2024	MT
12/01	Hisamitsu Pharmaceutical verhoogt de doelstellingen voor het boekjaar met een stijging van de negenmaands winst en de netto-omzet	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Hisamitsu Pharmaceutical : Notice of Convocation of the 122nd Annual General Meeting of Shareholders	25/04
Hisamitsu Pharmaceutical Attributable Profit Up 19% in Fiscal 2024	11/04
Hisamitsu Pharmaceutical : Earning Document	11/04
Hisamitsu Pharmaceutical : Notification of Completion of Construction of the New Research Laboratory “SAGA Global Research Center”	13/03
Hisamitsu Pharmaceutical Lifts Fiscal-Year Targets as Nine-Month Profit, Net Sales Rise	12/01
Hisamitsu Pharmaceutical Co., Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending February 29, 2024	11/01
Hisamitsu Pharmaceutical Co., Inc. Announces Dividend for the Second Quarter and Provides Dividend Guidance for the Full Year Ending February 29, 2024	11/01
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	26/12
Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback announced on July 13, 2023, has closed with 2,000,000 shares, representing 2.58% for ¥9,792.58 million.	25/12
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	05/12
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	05/12
Hisamitsu Pharmaceutical : Announcement regarding completion of partial transfer of assets, related to S-Cup and Lacalut from SSP Co., Ltd.	31-10-23
Hisamitsu Pharmaceutical’s Attributable Profit up 29.4% in Fiscal Q2 on Improved Net Sales	09-10-23
Hisamitsu Pharmaceutical : Earning Document	06-10-23
Hisamitsu Pharmaceutical : Earning Document	06-10-23
Hisamitsu Pharmaceutical Co., Inc. Reports Earnings Results for the Half Year Ended August 31, 2023	06-10-23
Hisamitsu Pharmaceutical : Notification regarding Skin Care Cosmetics with Microneedle Technology	20-09-23
Hisamitsu Pharmaceutical : Notification of the commencement of the Phase II clinical study of HP-6050 in Japan (a transdermal formulation for sedation)	19-09-23
Tranche Update on Hisamitsu Pharmaceutical Co., Inc.'s Equity Buyback Plan announced on July 13, 2023.	04-09-23
Hisamitsu Pharmaceutical : Notice Regarding Status of Acquisition of Treasury Shares	04-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Hisamitsu Pharmaceutical Co., Inc.

Aandelen

4530

JP3784600003

Andere talen

Filters